Former FTC director on 340B program: ‘Drug discounts are being captured by corporate hospital systems'
David Balto, a former policy director at the Federal Trade Commission (FTC), has raised concerns about the 340B drug discount program, alleging that it is being manipulated by corporate hospital systems and large pharmacies to the detriment of... Read More »